Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/23/19
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 03/11/20
End: 04/19/22
Due: 04/19/23
Phase: N/A
Priority: Normal
Start: 09/30/19
End: 08/31/20
Due: 08/31/21
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 01/12/17
Due: 01/12/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures | NCT03744728 | Accelerate Diagnostics, Inc. | user2@example.com | None | 2019-05-23 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |
| Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates | NCT04295915 | Accelerate Diagnostics, Inc. | user2@example.com | None | 2020-03-11 | 2022-04-19 | 2023-04-19 | - | - | 2025-07-14 |
| Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia | NCT03745014 | Accelerate Diagnostics, Inc. | user2@example.com | None | 2019-09-30 | 2020-08-31 | 2021-08-31 | - | - | 2025-07-14 |
| Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture | NCT02719769 | Accelerate Diagnostics, Inc. | user2@example.com | None | 2016-01-31 | 2017-01-12 | 2018-01-12 | - | - | 2025-07-14 |